SrivastavaS, et al.Abbreviated T-cell activation on the automated CliniMACS Prodigy device enhances bispecific CD19/22 Chimeric Antigen Receptor T-Cell viability and fold expansion, reducing total culture duration. ASH Annual Meeting 2018. Blood, 2018; 132: 4551
2.
ZhuH, et al.Metabolic reprogramming via deletion of CISH in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity. Cell Stem Cell, 2020; 27: 1–14.
